- Issuer ticker
-
SXTP
- Reported as of
-
03 Jun 2025
- Net transaction value
-
+$14,410
Source evidence
Original filing metadata and source links for verification.
4 source fields
- SEC form
-
4
- Accepted by SEC
-
05 Jun 2025, 20:53:09 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ Cheryl Xu
Key filing fact
Cheryl Xu filed Form 4 for 60 DEGREES PHARMACEUTICALS, INC. (SXTP) on 05 Jun 2025.
Key facts
- This page summarizes Cheryl Xu's Form 4 filing for 60 DEGREES PHARMACEUTICALS, INC. (SXTP).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 05 Jun 2025, 20:53.
Change
- Previous filing in this sequence was filed on 18 Dec 2024.
- Current net transaction value: +$14,410.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001976957
Primary reporting owner
XU CHERYL
- Relationship
-
Director
- Address
- C/O 60 DEGREES PHARMACEUTICALS, INC., 1025 CONNECTICUT AVENUE NW SUITE 1000, WASHINGTON
- Signature
- /s/ Cheryl Xu
- Signature date
- 05 Jun 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SXTP
transaction
Common Stock
Purchase
- Transaction value
- $8,610
- Shares
- +3,000
- Change %
- +28%
- Price
-
$2.87
- Shares after
- 13,816
- Date
- 03 Jun 2025
- Ownership
- Direct
- Footnotes
- F1
SXTP
transaction
Common Stock
Purchase
- Transaction value
- $5,800
- Shares
- +2,000
- Change %
- +14%
- Price
-
$2.90
- Shares after
- 15,816
- Date
- 03 Jun 2025
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote